ES2076085A1 - Antagonistas de angiotensina ii. - Google Patents

Antagonistas de angiotensina ii.

Info

Publication number
ES2076085A1
ES2076085A1 ES09301321A ES9301321A ES2076085A1 ES 2076085 A1 ES2076085 A1 ES 2076085A1 ES 09301321 A ES09301321 A ES 09301321A ES 9301321 A ES9301321 A ES 9301321A ES 2076085 A1 ES2076085 A1 ES 2076085A1
Authority
ES
Spain
Prior art keywords
angiotensin
antagonists
formula
compounds
antagonize
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09301321A
Other languages
English (en)
Other versions
ES2076085B1 (es
Inventor
Donald Bradford Boyd
Kenneth Lee Hauser
Sherryl Lynn Lifer
Winston Stanley Marshall
Alan David Palkowitz
William Pfeifer
Jon Kevin Reel
Richard Lee Simon
Mitchell Irvin Steinberg
Kumiko Takeuchi
Kenneth Jeff Thrasher
Celia Ann Whitesitt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Priority to ES9301321A priority Critical patent/ES2076085B1/es
Publication of ES2076085A1 publication Critical patent/ES2076085A1/es
Application granted granted Critical
Publication of ES2076085B1 publication Critical patent/ES2076085B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

ANTAGONISTAS DE ANGIOTENSINA II. LA INVENCION PROPORCIONA COMPUESTOS DE FORMULA (I) QUE ANTAGONIZA LA ANGIOTENSINA II EN LOS SITIOS RECEPTORES DEL CUERPO. TAMBIEN PROPORCIONA FORMULACIONES FARMACEUTICAS QUE COMPRENDEN UN COMPUESTO DE FORMULA I JUNTO CON UNO O MAS EXCIPIENTES ACEPTABLES FAMACEUTICAMENTE, VEHICULOS O DILUYENTES. TIENE APLICACION EN EL TRATAMIENTO DE LA HIPERTENSION, FALLO CARDIACO CONGESTIVO, INSUFICIENCIAS RENALES Y GLAUCOMA, ASI COMO EN LA MEJORA DEL RENDIMIENTO COGNITIVO.
ES9301321A 1993-06-15 1993-06-15 Antagonistas de angiotensina ii. Expired - Fee Related ES2076085B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9301321A ES2076085B1 (es) 1993-06-15 1993-06-15 Antagonistas de angiotensina ii.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9301321A ES2076085B1 (es) 1993-06-15 1993-06-15 Antagonistas de angiotensina ii.

Publications (2)

Publication Number Publication Date
ES2076085A1 true ES2076085A1 (es) 1995-10-16
ES2076085B1 ES2076085B1 (es) 1997-03-01

Family

ID=8282194

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9301321A Expired - Fee Related ES2076085B1 (es) 1993-06-15 1993-06-15 Antagonistas de angiotensina ii.

Country Status (1)

Country Link
ES (1) ES2076085B1 (es)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3872121A (en) * 1972-04-28 1975-03-18 Boehringer Sohn Ingelheim 2-(Phenyl-amino-2-imidazolines and salts thereof
EP0024829A1 (en) * 1979-08-07 1981-03-11 Farmos-Yhtyma Oy 4-Benzyl- and 4-benzoylimidazole derivatives, processes for their preparation and pharmaceutical compositions comprising the same
EP0438869A1 (en) * 1989-11-30 1991-07-31 Eli Lilly And Company Improvements in and relating to angiotensin II antagonists
EP0573271A1 (en) * 1992-06-03 1993-12-08 Eli Lilly And Company Angiotensin II antagonists

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3872121A (en) * 1972-04-28 1975-03-18 Boehringer Sohn Ingelheim 2-(Phenyl-amino-2-imidazolines and salts thereof
EP0024829A1 (en) * 1979-08-07 1981-03-11 Farmos-Yhtyma Oy 4-Benzyl- and 4-benzoylimidazole derivatives, processes for their preparation and pharmaceutical compositions comprising the same
EP0438869A1 (en) * 1989-11-30 1991-07-31 Eli Lilly And Company Improvements in and relating to angiotensin II antagonists
EP0573271A1 (en) * 1992-06-03 1993-12-08 Eli Lilly And Company Angiotensin II antagonists

Also Published As

Publication number Publication date
ES2076085B1 (es) 1997-03-01

Similar Documents

Publication Publication Date Title
AU3153097A (en) Pharmaceutical for treatment of neurological and neuropsychiatric disorders
WO2001042219A3 (en) Novel substituted phenanthridinones and methods of use thereof
EP2298298A3 (en) Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors
EP0490667A3 (en) Hiv protease inhibitors
CA2260145A1 (en) Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1
MX9605023A (es) Compuestos substituidos de imidazolidin-2,4-diona como substancias farmaceuticamente activas.
CA2018438A1 (en) Imidazolyl-alkenoic acids
AU4064597A (en) Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
AU6564990A (en) Substituted n-(imidazolyl)alkyl alanine derivatives
CA2371012A1 (en) 4-(1h-pyrrol-1-yl) imidazoles
CA2237189A1 (en) 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
WO2000027850A3 (en) Crf receptor antagonists and methods relating thereto
AU6682298A (en) Use of r-nsaid's for the prevention of alzheimer's disease
AU2001263130A1 (en) Bicyclic cyclohexylamines and their use as nmda receptor antagonists
EP1325922A3 (en) Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity
CA2282279A1 (en) Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
RU94046144A (ru) Замещенные (арилалкиламинобензил) аминопропионамидные производные, их применение, способы их получения, фармкомпозиция
CA2042934A1 (en) Treatment of ocular hypertension with an ocular synergistic combination
ES2076085A1 (es) Antagonistas de angiotensina ii.
IL125591A0 (en) 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide y receptor antagonists
EP0362941A3 (en) 4-Methyl and 4-ethyl substituted pyrrolidin-2-ones
TW349864B (en) Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
CA2162919A1 (en) Rectal Compositions
EP0974358A3 (en) Orally-administrable therapeutic and/or prophylactic agent for HTLV-1-related diseases

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19930615

Kind code of ref document: B1

Effective date: 19930615

FD1A Patent lapsed

Effective date: 20040503